In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: IFF’s current price exceeds the PERT-weighted fair value by 39.4%, indicating overvaluation. Financial health scores show poor profitability, efficiency, and growth, increasing risk. Monte Carlo analysis reveals high downside risk with median expected value ($17.28) well below the current price.